Does Intravenous Administration of Recombinant Tissue Plasminogen Activator for Ischemic Stroke can Cause Inferior Myocardial Infarction?

Abstract

Recombinant tissue plasminogen activator (rTPA) is one of the main portions of acute ischemic stroke management, but unfortunately has some complications. Myocardial infarction (MI) is a hazardous complication of administration of intravenous rTPA that has been reported recently. A 78-year-old lady was admitted for elective coronary artery bypass graft… (More)
DOI: 10.4081/ni.2016.6617

Topics

2 Figures and Tables

Cite this paper

@inproceedings{Almasi2016DoesIA, title={Does Intravenous Administration of Recombinant Tissue Plasminogen Activator for Ischemic Stroke can Cause Inferior Myocardial Infarction?}, author={Mostafa Almasi and Saeed Razmeh and Amir Hassan Habibi and Amir Hassan Rezaee}, booktitle={Neurology international}, year={2016} }